RxDoctor Payments Data

Kendra Friedman

Psychiatric/Mental Health · Jasper, INNPI 1952998486

Payments from drug & device makers

$773in general payments, 2019–2025

Across 38 payments — averaging $20.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$129
  • Takeda Pharmaceuticals U.S.A., Inc.$126
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$108
  • Axsome Therapeutics, Inc.$69
  • Ironshore Pharmaceuticals Inc.$50
  • Alkermes, Inc.$46
  • plus $246 from 8 others

What the payments were for

  • Food & beverage$773100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$773 in reported general payments places this provider in the 55th percentile of 729 psychiatric/mental health providers in Indiana.

See all psychiatric/mental health providers in Indiana

Medicare billing

Part B allowed, 2024
$20,185
Medicare patients
53
Services billed
286

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole18$27,419
TrintellixVortioxetine Hydrobromide18$20,169
CaplytaLumateperone Tosylate11$19,604
Paliperidone ErPaliperidone21$11,565
FetzimaLevomilnacipran Hcl12$5,658
Desvenlafaxine Succinate ErDesvenlafaxine Succinate65$5,653
Lisdexamfetamine Dimesylate12$1,963
Lurasidone Hcl12$1,799
Memantine Hcl16$1,562
Clozapine29$1,523
Oxcarbazepine12$1,425
Methylphenidate ErMethylphenidate Hcl13$1,332
Buspirone Hcl119$1,225
Divalproex Sodium ErDivalproex Sodium28$998
Mirtazapine58$972

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$126$20,16918 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$108$19,60411 claims
AbbVieFetzima$129$5,65812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 729 psychiatric/mental health providers in Indiana.

Other psychiatric/mental health in Jasper

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →